Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Patrick Hanley

Associate Professor

George Washington University

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

70%

Cell Biology

20%

T Cell Biology

50%

Immunotherapy

40%

Gene Therapy

30%

Cell Therapy

30%

Stem Cell Transplantation

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles13

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study

Article Link

Year:

2025

Review of flow cytometry as a tool for cell and gene therapy

Article Link

Year:

2024

Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital setting

Article Link

Year:

2024

Emerging frontiers in immuno- and gene therapy for cancer

Article Link

Year:

2023

Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

Article Link

Year:

2022

Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experience

Article Link

Year:

2022

ISCT survey on hospital practices to support externally manufactured investigational cell-gene therapy products

Article Link

Year:

2022

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted.

Article Link

Year:

2021

Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte cultures.

Article Link

Year:

2021

Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies.

Article Link

Year:

2021

Influence of administration of mesenchymal stromal cell on pediatric oxygenator performance and inflammatory response.

Article Link

Year:

2021

SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.

Article Link

Year:

2020

Processing laboratory considerations for multi-center cellular therapy clinical trials: a report from the Consortium for Pediatric Cellular Immunotherapy.

Article Link

Year:

2020

Collaborators5

Christopher Lazarski

Assistant Professor

George Washington University

UNITED STATES

Michael Keller

Assistant Professor

George Washington University

UNITED STATES

John Ligon

Assistant Professor

University of Florida

UNITED STATES

Catherine M. Bollard

Director/Professor

UNITED STATES

Jeremy Rubinstein

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

How do I reach out?

Meet Kite AI